Clinical Trials Browser

Phase 2 × Carcinoma, Pancreatic Ductal × folfirinox × Clear all

NCT02243007 2017-05-16

Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer

Phase 2 Terminated

7 enrolled 8 charts

Gastrointestinal

Carcinoma, Pancreatic Ductal